4.5 Article

Fatigue and chronic fatigue syndrome-like complaints in the general population

期刊

EUROPEAN JOURNAL OF PUBLIC HEALTH
卷 20, 期 3, 页码 251-257

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurpub/ckp113

关键词

chronic fatigue; epidemiology; lifestyle

向作者/读者索取更多资源

Background: Most knowledge on chronic fatigue (CF) and chronic fatigue syndrome (CFS) is based on clinical studies, not representative of the general population. This study aimed to assess the prevalence of fatigue in an adult general population and to identify associations with lifestyle factors. Methods: Total 22 500 residents of Nijmegen were selected at random and interviewed by questionnaire. Data on 9062 respondents (43% response) were analysed, taken into account age, gender and concomitant disease. Subjects were classified into four groups: not fatigued (NF, reference group), short-term fatigue (SF, < 6 months), chronic fatigue (CF, >= 6 months) and CFS-like fatigue (in accordance with the Center for Disease Control criteria for CFS, without clinical confirmation). Results: Our study population showed the following breakdown: NF 64.4% (95% CI 63.6-65.6%), SF 4.9% (95% CI 4.5-5.4%), CF 30.5% (95% CI 29.5-31.4%) and CFS-like fatigue 1.0% (95% CI 0.8-1.2%). Compared with the NF group, more of the CFS respondents were female [odds ratio (OR) = 1.9], obese (OR = 4.1), using analgesics (OR = 7.8), had a low alcohol intake (OR = 0.4), were eating less healthy food (OR = 0.5) and were physically less active (OR = 0.1). These associations largely applied to the SF and CF group. The fatigue could have been due to a concomitant disease in 34 and 55.5% of the SF and CF cases, respectively. Conclusion: The prevalence of CF in the general population appears to be much higher than previously indicated. Even with strict criteria for CFS, it is estimated that similar to 1% of the adult population experiences this condition. Interestingly, a large part of this group remains unrecognized by the general practitioner. A striking similarity in lifestyle pattern between SF, CF and CFS calls for further research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Substantial clinical benefit for Neck Disability Index revisited: establishing the goal for treatment?

Roland D. Donk, Andre L. M. Verbeek, Wim I. M. Verhagen, Hans Groenewoud, Allard T. F. Hosman, Ronald H. M. A. Bartels

EUROPEAN SPINE JOURNAL (2018)

Article Public, Environmental & Occupational Health

Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population

Johannes D. M. Otten, Guido van Schoor, Petronella G. M. Peer, Gerard J. den Heeten, Roland Holland, Mireille J. M. Broeders, Andre L. M. Verbeek

JOURNAL OF MEDICAL SCREENING (2018)

Article Neurosciences

Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans

Amelia Draper, Rebecca M. Koch, Jos W. M. van der Meer, Matthew A. J. Apps, Peter Pickkers, Masud Husain, Marieke E. van der Schaaf

NEUROPSYCHOPHARMACOLOGY (2018)

Article Genetics & Heredity

The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine

M. M. T. J. Broekman, D. R. Wong, G. J. A. Wanten, H. M. Roelofs, C. J. van Marrewijk, O. H. Klungel, A. L. M. Verbeek, P. M. Hooymans, H-J Guchelaar, H. Scheffer, L. J. J. Derijks, M. J. H. Coenen, D. J. de Jong

PHARMACOGENOMICS JOURNAL (2018)

Article Biochemistry & Molecular Biology

Metabolic Induction of Trained Immunity through the Mevalonate Pathway

Siroon Bekkering, Rob J. W. Arts, Boris Novakovic, Ioannis Kourtzelis, Charlotte D. C. C. van der Heijden, Yang Li, Calin D. Popa, Rob ter Horst, Julia van Tuijl, Romana T. Netea-Maier, Frank L. van de Veerdonk, Triantafyllos Chavakis, Leo A. B. Joosten, Jos W. M. van der Meer, Henk Stunnenberg, Niels P. Riksen, Mihai G. Netea

Letter Radiology, Nuclear Medicine & Medical Imaging

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise

I. J. E. Kouijzer, J. W. M. van der Meer, W. J. G. Oyen, C. P. Bleeker-Rovers

CLINICAL RADIOLOGY (2018)

Article Infectious Diseases

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome

Ruud P. H. Raijmakers, Anne F. M. Jansen, Stephan P. Keijmel, Teske Schoffelen, Anja Scholzen, Jos W. M. van der Meer, Leo A. B. Joosten, Mihai G. Netea, Marcel van Deuren, Chantal P. Bleeker-Rovers

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)

Review Medicine, General & Internal

Autoimmunity and B-cell dyscrasia in acute and chronic Q fever: A review of the literature

Anne F. M. Jansen, Ruud P. H. Raijmakers, Stephan P. Keijmel, Renate G. van der Molen, Gerald M. Vervoort, Jos W. M. van der Meer, Marcel van Deuren, Chantal P. Bleeker-Rovers

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)

Article Behavioral Sciences

Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome

Megan E. Roerink, Sean H. P. P. Roerink, Nadine Skoluda, Marieke E. van der Schaaf, Ad R. M. M. Hermus, Jos W. M. van der Meer, Hans Knoop, Urs M. Nater

HORMONES AND BEHAVIOR (2018)

Article Psychiatry

Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study

Ruud P. H. Raijmakers, Stephan P. Keijmel, Evi M. C. Breukers, Gijs Bleijenberg, Jos W. M. van der Meer, Chantal P. Bleeker-Rovers, Hans Knoop

JOURNAL OF PSYCHOSOMATIC RESEARCH (2019)

Editorial Material Medicine, General & Internal

Globalization of Traditional Chinese Medicine: what are the issues for ensuring evidence-based diagnosis and therapy?

R. Fears, G. E. Griffin, D. Larhammar, V. ter Meulen, J. W. M. van der Meer

JOURNAL OF INTERNAL MEDICINE (2020)

Review Microbiology

Immune recognition of putative alien microbial structures: Host-pathogen interactions in the age of space travel

Mihai G. Netea, Jorge Dominguez-Andres, Marc Eleveld, Huub J. M. op den Camp, Jos W. M. van der Meer, Neil A. R. Gow, Marien I. de Jonge

PLOS PATHOGENS (2020)

Editorial Material Medicine, Research & Experimental

BCG vaccination in health care providers and the protection against COVID-19

Mihai G. Netea, Jos W. M. van der Meer, Reinout van Crevel

Summary: Several COVID-19 vaccine candidates have shown promise, but uncertainty remains about their effectiveness and global distribution. Boosting innate immunity with vaccines like BCG may play a role in combating COVID-19, as evidenced by lower infection and seropositivity rates in BCG-vaccinated individuals. Further clinical trials are needed to explore the potential of BCG vaccination in COVID-19 and future pandemics.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biology

An open label trial of anakinra to prevent respiratory failure in COVID-19

Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N. Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, Eleni Karakike, Maria Saridaki, Georgia Loli, Aggelos Stefos, Danai Prasianaki, Sarah Georgiadou, Olga Tsachouridou, Vasileios Petrakis, Konstantinos Tsiakos, Maria Kosmidou, Vassiliki Lygoura, Maria Dareioti, Haralampos Milionis, Ilias C. Papanikolaou, Karolina Akinosoglou, Dimitra-Melia Myrodia, Areti Gravvani, Aliki Stamou, Theologia Gkavogianni, Konstantina Katrini, Theodoros Marantos, Ioannis P. Trontzas, Konstantinos Syrigos, Loukas Chatzis, Stamatios Chatzis, Nikolaos Vechlidis, Christina Avgoustou, Stamatios Chalvatzis, Miltiades Kyprianou, Jos Wm van der Meer, Jesper Eugen-Olsen, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis

Summary: Early suPAR-guided anakinra treatment can reduce the risk of severe respiratory failure and restore the pro-/anti-inflammatory balance in COVID-19 patients. The 30-day mortality rate was lower in the anakinra treatment group compared to the control group.
Article Biology

Evolution of cytokine production capacity in ancient and modern European populations

Jorge Dominguez-Andres, Yunus Kuijpers, Olivier B. Bakker, Martin Jaeger, Cheng-Jian Xu, Jos Wm Van der Meer, Mattias Jakobsson, Jaume Bertranpetit, Leo Ab Joosten, Yang Li, Mihai G. Netea

Summary: As our ancestors migrated, natural selection favored alleles advantageous in new environments, leading to varied susceptibility to diseases based on historical context, infection virulence, and geographical spread. The advent of Neolithic era in ancient European populations marked a significant shift in immune traits, promoting tolerance against intracellular pathogens and increased presence of traits related to inflammatory and auto-immune diseases.
暂无数据